RVT-501 0.5% ointment

DRUG2 trials

Sponsors

Dermavant Sciences GmbH

Conditions

Atopic Dermatitis

Phase 2

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

CompletedNCT02950922

Dermavant Sciences GmbHAtopic Dermatitis

Start: 2016-11-30End: 2017-07-03Updated: 2018-08-06

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

CompletedNCT03394677

Dermavant Sciences GmbHAtopic Dermatitis

Start: 2018-01-25End: 2018-07-02Updated: 2018-07-19